Multiple Sclerosis

Multiple Sclerosis
New Warnings for MS Drug Gilenya After FDA Review
New Warnings for MS Drug Gilenya After FDA Review Heart Risk Safety Concerns Added to Multiple Sclerosis Drug's Label WebMD Health News By Cari Nierenberg Reviewed by Laura J. Martin,...
Can Diet Affect Multiple Sclerosis?
Can Diet Affect Multiple Sclerosis? Medscape Medical News By Sue Hughes More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya Case New MS Drug Tecfidera: Q&A Leukemia...
Early-Stage MS Patients May Have Fracture Risk
Early-Stage MS Patients May Have Fracture Risk Study Suggests Vitamin D Deficiency May Put MS Patients at Risk for Osteoporosis WebMD Health News By Bill Hendrick Reviewed by Laura J....
Stem Cell Transplants May Show Promise for Multiple Sclerosis
Stem Cell Transplants May Show Promise for MS WebMD Health News By Denise Mann Reviewed by Louise Chang, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain...
Stress Management May Prevent MS Brain Lesions
Stress Management May Prevent MS Brain Lesions Multiple Sclerosis Patients Had Fewer New Brain Lesions During Treatment WebMD Health News By Salynn Boyles Reviewed by Laura J. Martin, MD More...
Can Diet Affect Multiple Sclerosis?
Can Diet Affect Multiple Sclerosis? Medscape Medical News By Sue Hughes More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya Case New MS Drug Tecfidera: Q&A Leukemia...
Early-Stage MS Patients May Have Fracture Risk
Early-Stage MS Patients May Have Fracture Risk Study Suggests Vitamin D Deficiency May Put MS Patients at Risk for Osteoporosis WebMD Health News By Bill Hendrick Reviewed by Laura J....
Can Diet Affect Multiple Sclerosis?
Can Diet Affect Multiple Sclerosis? Medscape Medical News By Sue Hughes More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya Case New MS Drug Tecfidera: Q&A Leukemia...
FDA approves Copaxone 3 times a week for MS
FDA Approves Copaxone 3 Times a Week for MS WebMD Health News Reviewed by Michael W. Smith, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya...
FDA Rejects MS Drug Lemtrada
FDA Rejects MS Drug Lemtrada WebMD Health News By Kathleen Doheny Reviewed by Michael W. Smith, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya Case...
Can 'Good' Cholesterol Protect Against MS?
Can 'Good' Cholesterol Protect Against MS? WebMD Health News By Kathleen Doheny Reviewed by Arefa Cassoobhoy, MD, MPH More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya...
FDA Investigates Brain Infection-Gilenya Case
FDA Investigates Brain Infection-Gilenya Case WebMD Health News By Kathleen Doheny Reviewed by Michael W. Smith, MD More from WebMD Multiple Sclerosis Rates Up 50% New MS Drug Tecfidera: Q&A...
New MS Drug Tecfidera: Q&A
New MS Drug: Q&A How Does Tecfidera Compare With Other MS Drugs? WebMD Health News By Kathleen Doheny Reviewed by Brunilda Nazario, MD More from WebMD Multiple Sclerosis Rates Up...
Nanoparticles Show Potential for Treating MS
Nanoparticles Show Potential for Treating MS WebMD Health News By Brenda Goodman, MA Reviewed by Louise Chang, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya...
Leukemia Drug Is Highly Effective MS Treatment
Leukemia Drug Is Highly Effective MS Treatment Alemtuzumab Lessens Relapses, Improves Disability WebMD Health News By Salynn Boyles Reviewed by Louise Chang, MD More from WebMD Multiple Sclerosis Rates Up...
Infertility Treatment May Worsen MS Symptoms
Infertility Treatment May Worsen MS Symptoms WebMD Health News By Salynn Boyles Reviewed by Louise Chang, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya Case...
Experimental MS Pill Continues to Show Promise
Experimental MS Pill Continues to Show Promise WebMD Health News By Salynn Boyles Reviewed by Louise Chang, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain Infection-Gilenya...
FDA Approves New Multiple Sclerosis Drug Aubagio
FDA Approves New Multiple Sclerosis Drug Aubagio WebMD Health News By Matt McMillen Reviewed by Laura J. Martin, MD More from WebMD Multiple Sclerosis Rates Up 50% FDA Investigates Brain...
Multiple Sclerosis Drugs May Not Delay Disability
Multiple Sclerosis Drugs May Not Delay Disability Interferon Beta Treatment Did Not Slow Progression of Disability in Study WebMD Health News By Salynn Boyles Reviewed by Louise Chang, MD More...
Botox May Ease Multiple Sclerosis Tremors
Botox May Ease Multiple Sclerosis Tremors Study Shows Botox Injections May Have a Role in Treating MS-Related Hand and Arm Tremors WebMD Health News By Denise Mann Reviewed by Louise...
New Warnings for MS Drug Gilenya After FDA Review
New Warnings for MS Drug Gilenya After FDA Review Heart Risk Safety Concerns Added to Multiple Sclerosis Drug's Label WebMD Health News By Cari Nierenberg Reviewed by Laura J. Martin,...
Treating Clogged Veins Improves MS, Study Says
Treating Clogged Veins Improves MS, Study Says Multiple Sclerosis Patients Feel Better After a Controversial Procedure, but Expert Offers Warning WebMD Health News By Laird Harrison Reviewed by Louise Chang,...
Past Pregnancies May Protect Against MS
Past Pregnancies May Protect Against MS Study: Multiple Sclerosis Risk May Drop by 50% After First Pregnancy WebMD Health News By Brenda Goodman, MA Reviewed by Louise Chang, MD More...
New Pill May Reduce Relapses in MS Patients
New Pill May Reduce Relapses in MS Patients Study Shows Teriflunomide Could Become a New Alternative to Injections WebMD Health News By Brenda Goodman, MA Reviewed by Laura J. Martin,...
57 Genes Now Linked to MS
57 Genes Now Linked to MS Majority of the New Genes Linked to Immune System, Pointing to Disease Origins, Researchers Say WebMD Health News By Kathleen Doheny Reviewed by Laura...
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.